BEVESPI AEROSPHERE Drug Patent Profile
✉ Email this page to a colleague
When do Bevespi Aerosphere patents expire, and what generic alternatives are available?
Bevespi Aerosphere is a drug marketed by Astrazeneca and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and eighty-three patent family members in thirty-one countries.
The generic ingredient in BEVESPI AEROSPHERE is formoterol fumarate; glycopyrrolate. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the formoterol fumarate; glycopyrrolate profile page.
DrugPatentWatch® Generic Entry Outlook for Bevespi Aerosphere
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be May 28, 2030. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for BEVESPI AEROSPHERE
| International Patents: | 183 |
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BEVESPI AEROSPHERE |
| What excipients (inactive ingredients) are in BEVESPI AEROSPHERE? | BEVESPI AEROSPHERE excipients list |
| DailyMed Link: | BEVESPI AEROSPHERE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for BEVESPI AEROSPHERE
Generic Entry Date for BEVESPI AEROSPHERE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
AEROSOL, METERED;INHALATION |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for BEVESPI AEROSPHERE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bastiaan Driehuys | Phase 2/Phase 3 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 4 |
| Los Angeles Biomedical Research Institute | Phase 4 |
Pharmacology for BEVESPI AEROSPHERE
| Drug Class | Anticholinergic beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists Cholinergic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for BEVESPI AEROSPHERE
US Patents and Regulatory Information for BEVESPI AEROSPHERE
BEVESPI AEROSPHERE is protected by seven US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of BEVESPI AEROSPHERE is ⤷ Try a Trial.
This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting BEVESPI AEROSPHERE
Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions for pulmonary delivery of long-acting .beta..sub.2 adrenergic receptor agonists and associated methods and systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | BEVESPI AEROSPHERE | formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 208294-001 | Apr 25, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Astrazeneca | BEVESPI AEROSPHERE | formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 208294-001 | Apr 25, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Astrazeneca | BEVESPI AEROSPHERE | formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 208294-001 | Apr 25, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Astrazeneca | BEVESPI AEROSPHERE | formoterol fumarate; glycopyrrolate | AEROSOL, METERED;INHALATION | 208294-001 | Apr 25, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for BEVESPI AEROSPHERE
When does loss-of-exclusivity occur for BEVESPI AEROSPHERE?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 6621
Estimated Expiration: ⤷ Try a Trial
Patent: 6806
Estimated Expiration: ⤷ Try a Trial
Patent: 6807
Estimated Expiration: ⤷ Try a Trial
Patent: 1758
Estimated Expiration: ⤷ Try a Trial
Patent: 2477
Estimated Expiration: ⤷ Try a Trial
Patent: 2478
Estimated Expiration: ⤷ Try a Trial
Australia
Patent: 10253770
Estimated Expiration: ⤷ Try a Trial
Patent: 10253776
Estimated Expiration: ⤷ Try a Trial
Patent: 10253950
Estimated Expiration: ⤷ Try a Trial
Patent: 15201037
Estimated Expiration: ⤷ Try a Trial
Patent: 17201709
Estimated Expiration: ⤷ Try a Trial
Patent: 18282272
Estimated Expiration: ⤷ Try a Trial
Patent: 20210160
Estimated Expiration: ⤷ Try a Trial
Brazil
Patent: 1011220
Estimated Expiration: ⤷ Try a Trial
Patent: 1011229
Estimated Expiration: ⤷ Try a Trial
Patent: 1011508
Estimated Expiration: ⤷ Try a Trial
Canada
Patent: 63936
Estimated Expiration: ⤷ Try a Trial
Patent: 63939
Estimated Expiration: ⤷ Try a Trial
Patent: 63941
Estimated Expiration: ⤷ Try a Trial
China
Patent: 2458364
Estimated Expiration: ⤷ Try a Trial
Patent: 2596176
Estimated Expiration: ⤷ Try a Trial
Patent: 2753152
Estimated Expiration: ⤷ Try a Trial
Patent: 5193773
Estimated Expiration: ⤷ Try a Trial
Patent: 7412212
Estimated Expiration: ⤷ Try a Trial
Patent: 7669664
Estimated Expiration: ⤷ Try a Trial
Croatia
Patent: 0161098
Estimated Expiration: ⤷ Try a Trial
Patent: 0161101
Estimated Expiration: ⤷ Try a Trial
Patent: 0161102
Estimated Expiration: ⤷ Try a Trial
Patent: 0200166
Estimated Expiration: ⤷ Try a Trial
Patent: 0200260
Estimated Expiration: ⤷ Try a Trial
Patent: 0200298
Estimated Expiration: ⤷ Try a Trial
Cyprus
Patent: 18030
Estimated Expiration: ⤷ Try a Trial
Patent: 18034
Estimated Expiration: ⤷ Try a Trial
Patent: 18040
Estimated Expiration: ⤷ Try a Trial
Patent: 22732
Estimated Expiration: ⤷ Try a Trial
Patent: 22749
Estimated Expiration: ⤷ Try a Trial
Denmark
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
European Patent Office
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
Hong Kong
Patent: 69026
Estimated Expiration: ⤷ Try a Trial
Patent: 69027
Estimated Expiration: ⤷ Try a Trial
Patent: 69307
Estimated Expiration: ⤷ Try a Trial
Patent: 18867
Estimated Expiration: ⤷ Try a Trial
Patent: 44669
Estimated Expiration: ⤷ Try a Trial
Patent: 47095
Estimated Expiration: ⤷ Try a Trial
Hungary
Patent: 29532
Estimated Expiration: ⤷ Try a Trial
Patent: 31229
Estimated Expiration: ⤷ Try a Trial
Patent: 31283
Estimated Expiration: ⤷ Try a Trial
Patent: 47803
Estimated Expiration: ⤷ Try a Trial
Patent: 47823
Estimated Expiration: ⤷ Try a Trial
Patent: 47834
Estimated Expiration: ⤷ Try a Trial
Patent: 900031
Estimated Expiration: ⤷ Try a Trial
Patent: 100018
Estimated Expiration: ⤷ Try a Trial
Israel
Patent: 6466
Estimated Expiration: ⤷ Try a Trial
Patent: 6467
Estimated Expiration: ⤷ Try a Trial
Patent: 6468
Estimated Expiration: ⤷ Try a Trial
Japan
Patent: 23383
Estimated Expiration: ⤷ Try a Trial
Patent: 73012
Estimated Expiration: ⤷ Try a Trial
Patent: 73013
Estimated Expiration: ⤷ Try a Trial
Patent: 69639
Estimated Expiration: ⤷ Try a Trial
Patent: 89356
Estimated Expiration: ⤷ Try a Trial
Patent: 48645
Estimated Expiration: ⤷ Try a Trial
Patent: 92124
Estimated Expiration: ⤷ Try a Trial
Patent: 76734
Estimated Expiration: ⤷ Try a Trial
Patent: 12528199
Estimated Expiration: ⤷ Try a Trial
Patent: 12528200
Estimated Expiration: ⤷ Try a Trial
Patent: 12528792
Estimated Expiration: ⤷ Try a Trial
Patent: 15187108
Estimated Expiration: ⤷ Try a Trial
Patent: 15199735
Estimated Expiration: ⤷ Try a Trial
Patent: 16041713
Estimated Expiration: ⤷ Try a Trial
Patent: 17222706
Estimated Expiration: ⤷ Try a Trial
Patent: 18008942
Estimated Expiration: ⤷ Try a Trial
Patent: 18048150
Estimated Expiration: ⤷ Try a Trial
Patent: 19108369
Estimated Expiration: ⤷ Try a Trial
Lithuania
Patent: 435024
Estimated Expiration: ⤷ Try a Trial
Patent: 435025
Estimated Expiration: ⤷ Try a Trial
Patent: 2019014
Estimated Expiration: ⤷ Try a Trial
Patent: 2021511
Estimated Expiration: ⤷ Try a Trial
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
Luxembourg
Patent: 0124
Estimated Expiration: ⤷ Try a Trial
Patent: 0208
Estimated Expiration: ⤷ Try a Trial
Mexico
Patent: 7126
Estimated Expiration: ⤷ Try a Trial
Patent: 0163
Estimated Expiration: ⤷ Try a Trial
Patent: 0164
Estimated Expiration: ⤷ Try a Trial
Patent: 11012684
Estimated Expiration: ⤷ Try a Trial
Patent: 11012685
Estimated Expiration: ⤷ Try a Trial
Patent: 11012783
Estimated Expiration: ⤷ Try a Trial
Patent: 20004077
Estimated Expiration: ⤷ Try a Trial
Montenegro
Patent: 631
Estimated Expiration: ⤷ Try a Trial
Netherlands
Patent: 0995
Estimated Expiration: ⤷ Try a Trial
Norway
Patent: 19026
Estimated Expiration: ⤷ Try a Trial
Patent: 21019
Estimated Expiration: ⤷ Try a Trial
Philippines
Patent: 017500778
Estimated Expiration: ⤷ Try a Trial
Poland
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
Portugal
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
Russian Federation
Patent: 80315
Estimated Expiration: ⤷ Try a Trial
Patent: 86297
Estimated Expiration: ⤷ Try a Trial
Patent: 13404
Estimated Expiration: ⤷ Try a Trial
Patent: 51771
Estimated Expiration: ⤷ Try a Trial
Patent: 11152960
Estimated Expiration: ⤷ Try a Trial
Patent: 11154083
Estimated Expiration: ⤷ Try a Trial
Patent: 11154148
Estimated Expiration: ⤷ Try a Trial
Patent: 15151358
Estimated Expiration: ⤷ Try a Trial
Patent: 16107464
Estimated Expiration: ⤷ Try a Trial
Patent: 16117972
Estimated Expiration: ⤷ Try a Trial
Patent: 20102859
Estimated Expiration: ⤷ Try a Trial
San Marino
Patent: 01600326
Estimated Expiration: ⤷ Try a Trial
Patent: 01600327
Estimated Expiration: ⤷ Try a Trial
Patent: 01600329
Estimated Expiration: ⤷ Try a Trial
Slovenia
Patent: 35023
Estimated Expiration: ⤷ Try a Trial
Patent: 35024
Estimated Expiration: ⤷ Try a Trial
Patent: 35025
Estimated Expiration: ⤷ Try a Trial
Patent: 06149
Estimated Expiration: ⤷ Try a Trial
Patent: 11926
Estimated Expiration: ⤷ Try a Trial
Patent: 11927
Estimated Expiration: ⤷ Try a Trial
South Africa
Patent: 1108275
Estimated Expiration: ⤷ Try a Trial
Patent: 1208100
Estimated Expiration: ⤷ Try a Trial
Patent: 1208101
Estimated Expiration: ⤷ Try a Trial
Patent: 1208102
Estimated Expiration: ⤷ Try a Trial
South Korea
Patent: 1748892
Estimated Expiration: ⤷ Try a Trial
Patent: 1926060
Estimated Expiration: ⤷ Try a Trial
Patent: 1976107
Estimated Expiration: ⤷ Try a Trial
Patent: 120015334
Estimated Expiration: ⤷ Try a Trial
Patent: 120026075
Estimated Expiration: ⤷ Try a Trial
Patent: 120034631
Estimated Expiration: ⤷ Try a Trial
Patent: 170070274
Estimated Expiration: ⤷ Try a Trial
Patent: 170104003
Estimated Expiration: ⤷ Try a Trial
Patent: 180130602
Estimated Expiration: ⤷ Try a Trial
Patent: 190049943
Estimated Expiration: ⤷ Try a Trial
Spain
Patent: 89135
Estimated Expiration: ⤷ Try a Trial
Patent: 92536
Estimated Expiration: ⤷ Try a Trial
Patent: 93429
Estimated Expiration: ⤷ Try a Trial
Patent: 72253
Estimated Expiration: ⤷ Try a Trial
Patent: 74367
Estimated Expiration: ⤷ Try a Trial
Patent: 74391
Estimated Expiration: ⤷ Try a Trial
Taiwan
Patent: 39979
Estimated Expiration: ⤷ Try a Trial
Patent: 46094
Estimated Expiration: ⤷ Try a Trial
Patent: 32926
Estimated Expiration: ⤷ Try a Trial
Patent: 33898
Estimated Expiration: ⤷ Try a Trial
Patent: 46980
Estimated Expiration: ⤷ Try a Trial
Patent: 95723
Estimated Expiration: ⤷ Try a Trial
Patent: 07700
Estimated Expiration: ⤷ Try a Trial
Patent: 17511
Estimated Expiration: ⤷ Try a Trial
Patent: 92140
Estimated Expiration: ⤷ Try a Trial
Patent: 1109049
Estimated Expiration: ⤷ Try a Trial
Patent: 1109050
Estimated Expiration: ⤷ Try a Trial
Patent: 1109051
Estimated Expiration: ⤷ Try a Trial
Patent: 1642836
Estimated Expiration: ⤷ Try a Trial
Patent: 1700123
Estimated Expiration: ⤷ Try a Trial
Patent: 1808372
Estimated Expiration: ⤷ Try a Trial
Patent: 1919730
Estimated Expiration: ⤷ Try a Trial
Patent: 1936174
Estimated Expiration: ⤷ Try a Trial
Patent: 2114642
Estimated Expiration: ⤷ Try a Trial
Ukraine
Patent: 9529
Estimated Expiration: ⤷ Try a Trial
Patent: 9530
Estimated Expiration: ⤷ Try a Trial
Patent: 9531
Estimated Expiration: ⤷ Try a Trial
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering BEVESPI AEROSPHERE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Luxembourg | C00208 | ⤷ Try a Trial | |
| Spain | 2774367 | ⤷ Try a Trial | |
| Taiwan | I717511 | ⤷ Try a Trial | |
| Japan | 2015199735 | ２つ以上の活性剤を呼吸器送達するための組成物、方法および系 (COMPOSITION, METHOD AND SYSTEM FOR DELIVERING TWO OR MORE ACTIVATORS TO RESPIRATORY ORGAN) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for BEVESPI AEROSPHERE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2435025 | 19C1040 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON DE GLYCOPYRROLATE (Y COMPRIS TOUS SELS, ESTERS, ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI) ET DE FORMOTEROL (Y COMPRIS TOUS SELS, ESTERS, ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI); NAT. REGISTRATION NO/DATE: EU/1/18/1339 20181220; FIRST REGISTRATION: - EU/1/18/1339 20181220 |
| 2435025 | 2019026 | Norway | ⤷ Try a Trial | PRODUCT NAME: KOMBINASJON AV GLYKOPYRROLAT (INKLUDERT EVENTUELLE FARMASOEYTISK AKSEPTABLE SALTER, ESTERE ELLER ENANTIOMERER DERAV) OG FORMOTEROL (INNBEFATTENDE HVILKE SOM HELST FARMASOEYTISK AKSEPTABLE SALTER, ESTERE ELLER ENANTIOMERER DERAV); REG. NO/DATE: EU/1/18/1339 20190104 |
| 2435024 | PA2021511 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: FORMOTEROLIO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS), GLIKOPIROLATO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENANTIOMERUS) IR BUDEZONIDO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS) DERINYS; REGISTRATION NO/DATE: EU/1/20/1498 20201209 |
| 2435024 | 2190014-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF FORMOTEROL INCLUDING ANY PHARMACEUUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, GLYCOPYRROLATE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS, OR SOLVATES THEREOF, AND BUDESONIDE INCLUDING ANY PHARMACEUTICALLY ACCEPTABLE SALT, ESTERS ORSOLVATES THEREOF; REG. NO/DATE: EU/1/20/1498 20201210 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
